Latus Bio

Philadelphia, United States

Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.

May 2026

Series A

Top Investors

Gaingels8VCDCVC BioModi VenturesBioAdvance

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Latus Bio's investors?

Latus Bio's investors include Gaingels, 8VC, DCVC Bio, Modi Ventures, BioAdvance.

Where is Latus Bio headquartered?

Latus Bio is headquartered in Philadelphia, United States.

What does Latus Bio do?

Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.

What stage is Latus Bio at?

Latus Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 4, 2026.

MLA

"Latus Bio — Funding & Investors." VCBacked, May 4, 2026, https://www.vcbacked.co/company/latus-bio. Accessed June 3, 2026.

APA

VCBacked. (2026). Latus Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/latus-bio

Wikipedia (cite web)

{{cite web |title=Latus Bio — Funding & Investors |url=https://www.vcbacked.co/company/latus-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 4, 2026.